IGF2BP3, one of the readers of m6A methylation, has been shown to play a regulatory role in many diseases including cancer (40–42) and cardiovascular diseases (43, 44); however, its role in RA is unknown. Here, IGF2BP3 is linked to rheumatoid arthritis.